Compounds > adenosine diphosphate ribose

adenosine diphosphate ribose and Multiple Myeloma

adenosine diphosphate ribose has been researched along with Multiple Myeloma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Elnenaei, MO; Gujar, SA; Kennedy, BE; Reiman, A; Sadek, M	1
Barlogie, B; Epstein, J; FitzGerald, DJ; Kreitman, RJ; Pastan, I; Siegall, CB	1

Other Studies

2 other study(ies) available for adenosine diphosphate ribose and Multiple Myeloma

Article	Year
Targeting NAD Trends in cancer, 2020, Volume: 6, Issue:1 Topics: Acrylamides; Adenosine; Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytokines; Drug Synergism; Humans; Membrane Glycoproteins; Multiple Myeloma; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Piperidines; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Escape; Warburg Effect, Oncologic	2020
Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma. Blood, 1992, Apr-01, Volume: 79, Issue:7 Topics: Adenosine Diphosphate Ribose; ADP Ribose Transferases; Adult; Aged; Bacterial Toxins; Binding, Competitive; Bone Marrow; Bone Marrow Purging; Cell Survival; Exotoxins; Humans; Interleukin-6; Middle Aged; Multiple Myeloma; Pseudomonas aeruginosa Exotoxin A; Receptors, Interleukin-2; Recombinant Fusion Proteins; Recombinant Proteins; Virulence Factors	1992

Article

Year

Targeting NAD

Trends in cancer, 2020, Volume: 6, Issue:1

Topics: Acrylamides; Adenosine; Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytokines; Drug Synergism; Humans; Membrane Glycoproteins; Multiple Myeloma; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Piperidines; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Escape; Warburg Effect, Oncologic

2020

Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma.

Blood, 1992, Apr-01, Volume: 79, Issue:7

Topics: Adenosine Diphosphate Ribose; ADP Ribose Transferases; Adult; Aged; Bacterial Toxins; Binding, Competitive; Bone Marrow; Bone Marrow Purging; Cell Survival; Exotoxins; Humans; Interleukin-6; Middle Aged; Multiple Myeloma; Pseudomonas aeruginosa Exotoxin A; Receptors, Interleukin-2; Recombinant Fusion Proteins; Recombinant Proteins; Virulence Factors

1992